Carnegie Investment Counsel’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $329K | Sell |
3,450
-1,600
| -32% | -$154K | 0.01% | 464 |
|
|
2026
Q1 | $523K | Sell |
5,050
-1,000
| -17% | -$113K | 0.01% | 408 |
|
|
2025
Q4 | $610K | Sell |
6,050
-302
| -5% | -$32.8K | 0.01% | 378 |
|
|
2025
Q3 | $783K | Sell |
6,352
-1,400
| -18% | -$174K | 0.01% | 340 |
|
|
2025
Q2 | $931K | Buy |
7,752
+950
| +14% | +$127K | 0.02% | 315 |
|
|
2025
Q1 | $947K | Buy |
6,802
+313
| +5% | +$47.8K | 0.02% | 288 |
|
|
2024
Q4 | $1.05M | Hold |
6,489
| – | – | 0.03% | 262 |
|
|
2024
Q3 | $1.06M | Hold |
6,489
| – | – | 0.03% | 264 |
|
|
2024
Q2 | $886K | Hold |
6,489
| – | – | 0.03% | 277 |
|
|
2024
Q1 | $994K | Sell |
6,489
-126
| -2% | -$18.8K | 0.03% | 290 |
|
|
2023
Q4 | $943K | Sell |
6,615
-957
| -13% | -$128K | 0.03% | 283 |
|
|
2023
Q3 | $992K | Hold |
7,572
| – | – | 0.04% | 273 |
|
|
2023
Q2 | $1.2M | Sell |
7,572
-276
| -4% | -$44.5K | 0.04% | 261 |
|
|
2023
Q1 | $1.24M | Sell |
7,848
-1
| -0% | -$150 | 0.05% | 262 |
|
|
2022
Q4 | $1.1M | Buy |
7,849
+2
| +0% | +$284 | 0.05% | 271 |
|
|
2022
Q3 | $1.01M | Sell |
7,847
-472
| -6% | -$68.1K | 0.05% | 261 |
|
|
2022
Q2 | $1.17M | Buy |
8,319
+322
| +4% | +$46K | 0.05% | 241 |
|
|
2022
Q1 | $1.11M | Buy |
7,997
+957
| +14% | +$147K | 0.04% | 256 |
|
|
2021
Q4 | $1.23M | Sell |
7,040
-957
| -12% | -$160K | 0.04% | 250 |
|
|
2021
Q3 | $1.32M | Sell |
7,997
-1,250
| -14% | -$215K | 0.05% | 226 |
|
|
2021
Q2 | $1.66M | Sell |
9,247
-20
| -0.2% | -$3.65K | 0.06% | 208 |
|
|
2021
Q1 | $1.78M | Sell |
9,267
-7
| -0.1% | -$1.35K | 0.07% | 192 |
|
|
2020
Q4 | $1.87M | Sell |
9,274
-75
| -0.8% | -$15.5K | 0.08% | 182 |
|
|
2020
Q3 | $1.97M | Hold |
9,349
| – | – | 0.1% | 161 |
|
|
2020
Q2 | $2.05M | Hold |
9,349
| – | – | 0.12% | 157 |
|
|
2020
Q1 | $1.62M | Sell |
9,349
-400
| -4% | -$66.1K | 0.11% | 161 |
|
|
2019
Q4 | $1.5M | Buy |
9,749
+2,000
| +26% | +$299K | 0.09% | 190 |
|
|
2019
Q3 | $1.18M | Sell |
7,749
-2,000
| -21% | -$316K | 0.08% | 198 |
|
|
2019
Q2 | $1.49M | Sell |
9,749
-99
| -1% | -$15.1K | 0.1% | 181 |
|
|
2019
Q1 | $1.58M | Buy |
9,848
+99
| +1% | +$15.4K | 0.11% | 180 |
|
|
2018
Q4 | $1.5M | Sell |
9,749
-7,157
| -42% | -$1.11M | 0.14% | 157 |
|
|
2018
Q3 | $2.74M | Buy |
16,906
+7,157
| +73% | +$1.02M | 0.22% | 116 |
|
|
2018
Q2 | $1.38M | Buy |
9,749
+76
| +0.8% | +$9.38K | 0.11% | 175 |
|
|
2018
Q1 | $1.17M | Sell |
9,673
-662
| -6% | -$88.9K | 0.1% | 178 |
|
|
2017
Q4 | $1.33M | Hold |
10,335
| – | – | 0.12% | 185 |
|
|
2017
Q3 | $1.33M | Hold |
10,335
| – | – | 0.16% | 159 |
|
|
2017
Q2 | $1.37M | Buy |
10,335
+200
| +2% | +$27K | 0.17% | 151 |
|
|
2017
Q1 | $1.35M | Sell |
10,135
-170
| -2% | -$22K | 0.17% | 144 |
|
|
2016
Q4 | $1.26M | Hold |
10,305
| – | – | 0.17% | 137 |
|
|
2016
Q3 | $1.26M | Sell |
10,305
-433
| -4% | -$56.7K | 0.18% | 130 |
|
|
2016
Q2 | $1.41M | Sell |
10,738
-314
| -3% | -$40.7K | 0.2% | 127 |
|
|
2016
Q1 | $1.39M | Sell |
11,052
-1,600
| -13% | -$203K | 0.21% | 118 |
|
|
2015
Q4 | $1.63M | Sell |
12,652
-99
| -0.8% | -$12.3K | 0.28% | 97 |
|
|
2015
Q3 | $1.55M | Buy |
12,751
+1,215
| +11% | +$136K | 0.27% | 95 |
|
|
2015
Q2 | $1.2M | Buy |
11,536
+1,163
| +11% | +$125K | 0.21% | 113 |
|
|
2015
Q1 | $1.15M | Buy |
10,373
+2,190
| +27% | +$238K | 0.2% | 117 |
|
|
2014
Q4 | $878K | Buy |
8,183
+2,207
| +37% | +$221K | 0.16% | 131 |
|
|
2014
Q3 | $574K | Sell |
5,976
-2,357
| -28% | -$213K | 0.11% | 177 |
|
|
2014
Q2 | $762K | Buy |
8,333
+2,257
| +37% | +$202K | 0.17% | 123 |
|
|
2014
Q1 | $535K | Sell |
6,076
-135
| -2% | -$11.9K | 0.14% | 140 |
|
|
2013
Q4 | $576K | Buy |
6,211
+368
| +6% | +$33.1K | 0.15% | 136 |
|
|
2013
Q3 | $477K | Sell |
5,843
-150
| -3% | -$12.7K | 0.15% | 140 |
|
|
2013
Q2 | $498K | Buy |
+5,993
| New | +$516K | 0.16% | 131 |
|
Other funds holding CLX
CIM
EIC
NI
VF
Carnegie Investment Counsel's CLX Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its Clorox (CLX) stake by 32% in Q2 2026, selling an estimated $154K and leaving 3,450 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #464.
Carnegie Investment Counsel first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.74M in Q3 2018. 598 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Carnegie Investment Counsel held 3,450 shares of Clorox worth $329K as of Q2 2026.
- Carnegie Investment Counsel sold 1,600 Clorox shares in Q2 2026, an estimated $154K.
- Clorox made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #464 holding.
- Carnegie Investment Counsel first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
- Carnegie Investment Counsel's Clorox position peaked at $2.74M in Q3 2018.
- 598 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.